These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 1707655)

  • 21. Peptide binding to surface class II molecules is the major pathway of formation of immunogenic class II-peptide complexes for viable antigen presenting cells.
    Nygard NR; Giacoletto KS; Bono C; Gorka J; Kompelli S; Schwartz BD
    J Immunol; 1994 Feb; 152(3):1082-93. PubMed ID: 8301118
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Six unrelated HLA-DR-matched adults recognize identical CD4+ T cell epitopes from influenza A haemagglutinin that are not simply peptides with high HLA-DR binding affinities.
    Gelder C; Davenport M; Barnardo M; Bourne T; Lamb J; Askonas B; Hill A; Welsh K
    Int Immunol; 1998 Feb; 10(2):211-22. PubMed ID: 9533449
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antibody recognition of an immunogenic influenza hemagglutinin-human leukocyte antigen class II complex.
    Nygard NR; Bono C; Brown LR; Gorka J; Giacoletto KS; Schaiff WT; Graham MB; McCourt DW; Kabeer M; Braciale VL
    J Exp Med; 1991 Jul; 174(1):243-51. PubMed ID: 2056278
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Utilization of soluble fusion proteins for induction of T cell proliferation.
    Kirschmann DA; De Ciechi PA; Bono CP; Zacheis ML; Schwartz BD; Woulfe SL
    Cell Immunol; 1995 Feb; 160(2):193-8. PubMed ID: 7720079
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Binding of a major T cell epitope of mycobacteria to a specific pocket within HLA-DRw17(DR3) molecules.
    Geluk A; Bloemhoff W; De Vries RR; Ottenhoff TH
    Eur J Immunol; 1992 Jan; 22(1):107-13. PubMed ID: 1370411
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Crystal structure of the human class II MHC protein HLA-DR1 complexed with an influenza virus peptide.
    Stern LJ; Brown JH; Jardetzky TS; Gorga JC; Urban RG; Strominger JL; Wiley DC
    Nature; 1994 Mar; 368(6468):215-21. PubMed ID: 8145819
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Characterizing immunodominant and protective influenza hemagglutinin epitopes by functional activity and relative binding to major histocompatibility complex class II sites.
    Rajnavölgyi E; Horváth A; Gogolák P; Tóth GK; Fazekas G; Fridkin M; Pecht I
    Eur J Immunol; 1997 Dec; 27(12):3105-14. PubMed ID: 9464794
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Self and foreign peptides interact with intact and disassembled MHC class II antigen HLA-DR via tryptophan pockets.
    Kropshofer H; Bohlinger I; Max H; Kalbacher H
    Biochemistry; 1991 Sep; 30(38):9177-87. PubMed ID: 1892827
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Binding analysis of 95 HIV gp120 peptides to HLA-DR1101 and -DR0401 evidenced many HLA-class II binding regions on gp120 and suggested several promiscuous regions.
    Gaudebout P; Zeliszewski D; Golvano JJ; Pignal C; Le Gac S; Borras-Cuesta F; Sterkers G
    J Acquir Immune Defic Syndr Hum Retrovirol; 1997 Feb; 14(2):91-101. PubMed ID: 9052717
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Predominant naturally processed peptides bound to HLA-DR1 are derived from MHC-related molecules and are heterogeneous in size.
    Chicz RM; Urban RG; Lane WS; Gorga JC; Stern LJ; Vignali DA; Strominger JL
    Nature; 1992 Aug; 358(6389):764-8. PubMed ID: 1380674
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Peptide-mediated modulation of T-cell allorecognition.
    Eckels DD; Gorski J; Rothbard J; Lamb JR
    Proc Natl Acad Sci U S A; 1988 Nov; 85(21):8191-5. PubMed ID: 2973061
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Analysis of binding capacities between HLA class II molecules and synthetic peptides HA307-319].
    Ikeda K; Katagiri M
    Hokkaido Igaku Zasshi; 1993 May; 68(3):318-24. PubMed ID: 8319931
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Generation of functional HLA-DR*1101 tetramers receptive for loading with pathogen- or tumour-derived synthetic peptides.
    Moro M; Cecconi V; Martinoli C; Dallegno E; Giabbai B; Degano M; Glaichenhaus N; Protti MP; Dellabona P; Casorati G
    BMC Immunol; 2005 Dec; 6():24. PubMed ID: 16329759
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Monoclonal antibodies to HLA-DP, DQ, and DR determinants: functional effects on the activation and proliferation of normal and EBV-transformed B cells.
    Howard DR; Eaves AC; Takei F
    Exp Hematol; 1986 Oct; 14(9):887-95. PubMed ID: 2428652
    [TBL] [Abstract][Full Text] [Related]  

  • 35. MHC class II binding of peptides derived from HLA-DR 1.
    Harris PE; Liu Z; Suciu-Foca N
    J Immunol; 1992 Apr; 148(7):2169-74. PubMed ID: 1545124
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Involvement of zinc in the binding of Mycoplasma arthritidis-derived mitogen to the proximity of the HLA-DR binding groove regardless of histidine 81 of the beta chain.
    Etongué-Mayer P; Langlois MA; Ouellette M; Li H; Younes S; Al-Daccak R; Mourad W
    Eur J Immunol; 2002 Jan; 32(1):50-8. PubMed ID: 11754003
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The structure of an intermediate in class II MHC maturation: CLIP bound to HLA-DR3.
    Ghosh P; Amaya M; Mellins E; Wiley DC
    Nature; 1995 Nov; 378(6556):457-62. PubMed ID: 7477400
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Degeneracy of T cell receptor recognition of an influenza virus hemagglutinin epitope restricted by HLA-DQ and -DR class II molecules.
    Jones CM; Lake RA; Lamb JR; Faith A
    Eur J Immunol; 1994 May; 24(5):1137-42. PubMed ID: 7514130
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Recognition of the influenza hemagglutinin by class II MHC-restricted T lymphocytes and antibodies. I. Site definition and implications for antigen presentation and T lymphocyte recognition.
    Brown LR; Nygard NR; Graham MB; Bono C; Braciale VL; Gorka J; Schwartz BD; Braciale TJ
    J Immunol; 1991 Oct; 147(8):2677-84. PubMed ID: 1717572
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Involvement of class II beta-chain amino acid residues 85 and 86 in T-cell allorecognition.
    Eckels DD; Geiger MJ; Sell TW; Gorski JA
    Hum Immunol; 1990 Mar; 27(3):240-53. PubMed ID: 1692822
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.